Arvinas (ARVN) Retained Earnings (2017 - 2026)
Arvinas (ARVN) recorded quarterly Retained Earnings of -$1.7 billion in Q1 2026, down 3.57% quarter-over-quarter from -$1.6 billion in Q4 2025, and down 15.28% on a YoY basis from -$2.0 billion in Q1 2025.
Arvinas (ARVN) Retained Earnings (2017 - 2026) Analysis & Trends
Arvinas' Retained Earnings history runs 10 years deep, the most recent figure standing at -$1.7 billion for Q1 2026.
- In Q1 2026, Retained Earnings fell 15.28% year-over-year to -$1.7 billion; the TTM figure through Mar 2026 stood at -$1.7 billion (down 15.28% YoY), while the FY2025 annual figure was -$1.6 billion, down 161340.0% from the prior year.
- Retained Earnings was -$1.7 billion for Q1 2026 at Arvinas, down from -$1.6 billion in the prior quarter.
- In the past five years, Retained Earnings ranged from a high of $4.1 million in Q3 2024 to a low of -$1.7 billion in Q1 2026.
- Historically, Retained Earnings has averaged -$774.9 million across 5 years, with a median of -$1.1 billion in 2023.
- The sharpest annual moves came in 2024 and 2025: Retained Earnings surged 144.57% in 2024, then plunged 161340.0% in 2025.
- A 5-year view of Retained Earnings shows it stood at -$19.2 million in 2022, then slumped by 6841.15% to -$1.3 billion in 2023, then jumped by 100.08% to $1.0 million in 2024, then slumped by 161340.0% to -$1.6 billion in 2025, then dropped by 3.57% to -$1.7 billion in 2026.
- The last three Retained Earnings figures came in at -$1.7 billion (Q1 2026), -$1.6 billion (Q4 2025), and -$1.5 billion (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | -153.89 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -211.85 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 1.00 Bn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 130.89 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -279.00 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -1.88 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 14.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -838.07 Mn |
| 10 | Arvinas | 492.16 Mn | -122.74 Mn | - | -1.67 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.67 Bn |
| Dec 31, 2025 | -1.61 Bn |
| Sep 30, 2025 | -1.55 Bn |
| Jun 30, 2025 | -1.51 Bn |
| Mar 31, 2025 | -1.45 Bn |
| Dec 31, 2024 | 1.00 Mn |
| Sep 30, 2024 | 4.10 Mn |
| Jun 30, 2024 | -1.44 Bn |
| Mar 31, 2024 | -1.40 Bn |
| Dec 31, 2023 | -1.33 Bn |
| Sep 30, 2023 | -9.20 Mn |
| Jun 30, 2023 | -1.11 Bn |
| Mar 31, 2023 | -12.60 Mn |
| Dec 31, 2022 | -19.20 Mn |
| Sep 30, 2022 | -24.80 Mn |
| Jun 30, 2022 | -22.00 Mn |
| Mar 31, 2022 | -18.70 Mn |
| Dec 31, 2021 | -682.90 Mn |
| Sep 30, 2021 | -629.89 Mn |
| Jun 30, 2021 | -486,544.00 |